Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,881 | 65,243 | 69,744 | 74,749 | 25,037 |
| TOTAL | $60,731 | $66,840 | $71,341 | $76,934 | $27,257 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 1 | 2 | 4 |
| Other Non-Current Assets | 308 | 358 | 406 | 454 | 501 |
| TOTAL | $308 | $358 | $407 | $456 | $505 |
| Total Assets | $61,039 | $67,198 | $71,748 | $77,391 | $27,762 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,746 | 1,309 | 1,446 | 2,375 | 951 |
| Accrued Expenses | 1,962 | 2,188 | 1,924 | 1,470 | 1,855 |
| TOTAL | $5,019 | $3,756 | $3,577 | $4,003 | $2,929 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 147 | 231 | 314 | 395 | 458 |
| TOTAL | $147 | $231 | $314 | $395 | $458 |
| Total Liabilities | $5,166 | $3,988 | $3,891 | $4,398 | $3,387 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,451 | 28,449 | 28,435 | 28,424 | 22,278 |
| Common Shares | 9 | 9 | 9 | 9 | 7 |
| Retained earnings | -69,177 | -60,704 | -54,384 | -47,423 | -46,834 |
| TOTAL | $55,873 | $63,210 | $67,857 | $72,993 | $24,374 |
| Total Liabilities And Equity | $61,039 | $67,198 | $71,748 | $77,391 | $27,762 |